FSEV ETF Forecast & Price Targets

Compare

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

FSEV Analyst Ratings

Moderate Buy

287 Buy

129 Hold

13 Sell

Based on the consensus analyst ratings on 429 stocks held in FSEV.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

FSEV 12 Month Forecast

Average Price Target

$32.32

Based on the average price target on 429 stocks. Derived from Wall Street analysts offering 12-month price targets on FSEV holdings in the last 3 months. The average price target is $32.32 with a high forecast of $36.90 and a low forecast of $28.11. The average price target represents a 17.24% change from the last price of $27.56.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"24":"$24","37":"$37","27.25":"$27.3","30.5":"$30.5","33.75":"$33.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":36.895,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$36.90</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":32.315,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$32.31</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":28.114,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$28.11</span>\n  </div></div>","useHTML":true}}],"tickPositions":[24,27.25,30.5,33.75,37],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27.08,27.834999999999997,28.59,29.345,30.1,30.855,31.61,32.365,33.120000000000005,33.875,34.63,35.385000000000005,36.14,{"y":36.895,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27.08,27.482692307692307,27.885384615384613,28.288076923076922,28.690769230769227,29.093461538461536,29.496153846153845,29.89884615384615,30.30153846153846,30.70423076923077,31.106923076923074,31.509615384615383,31.91230769230769,{"y":32.315,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,27.08,27.15953846153846,27.239076923076922,27.318615384615384,27.398153846153846,27.47769230769231,27.55723076923077,27.63676923076923,27.71630769230769,27.795846153846153,27.875384615384615,27.954923076923077,28.03446153846154,{"y":28.114,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":25.27,"date":1756684800000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.27,"date":1759276800000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.27,"date":1761955200000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.27,"date":1764547200000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.27,"date":1767225600000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.27,"date":1769904000000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.27,"date":1772323200000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.27,"date":1775001600000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.27,"date":1777593600000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.27,"date":1777593600000,"info":"<div>Price: <b>$25<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":25.53,"date":1780272000000,"info":"<div>Price: <b>$26<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":26.61,"date":1782864000000,"info":"<div>Price: <b>$27<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":27.08,"date":1785715200000,"info":"<div>Price: <b>$27<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$36.90

Average Price Target$32.32

Lowest Price Target$28.11

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

FSEV Stocks With Highest Upside Potential

ALLO

Allogene Therapeutics

6 Buy

1 Hold

0 Sell

Strong Buy

―

NKTX

Nkarta, Inc.

6 Buy

0 Hold

0 Sell

Strong Buy

―

CMPX

Compass Therapeutics, Inc.

7 Buy

0 Hold

0 Sell

Strong Buy

―

KPTI

Karyopharm Therapeutics INC

3 Buy

2 Hold

0 Sell

Moderate Buy

―

RCKT

Rocket Pharma

5 Buy

3 Hold

0 Sell

Moderate Buy

―

FSEV Stocks With Highest Downside Potential

No stocks with downside potential were found for this ETF

Please check back later or explore other ETFs for potential investment opportunities.

FSEV ETF FAQ

What is FSEV’s average 12-month price target, according to analysts?

Based on analyst ratings, FSEV’s 12-month average price target is 32.32.

What is FSEV’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for FSEV, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is FSEV a Buy, Sell or Hold?

FSEV has a consensus rating of Moderate Buy which is based on 287 buy ratings, 129 hold ratings and 13 sell ratings.

What is FSEV’s price target?

The average price target for FSEV is 32.32. This is based on 429 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $36.90 ,the lowest forecast is $28.11. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about FSEV?

FSEV’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 429 Wall Streets Analysts.

How can I buy shares of FSEV?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing